Chinese ‘Super Vaccine’ for Covid 19, China claims 100% efficacy with its new vaccine

-

China super vaccine coronavirus

China has shocked the world with an announcement of a ‘super vaccine’ being developed to prevent Covid 19 infection. Beijing claims that one million people have already been vaccinated without any side effects. At the same time, China also claims that none of them became infected with the Covid 19 after being vaccinated. This is why this vaccine is called ‘Super Vaccine’.

The covid vaccine, manufactured by a Chinese drug manufacturer Sinopharm, however, has not yet completed the final phase of its clinical trial. Nevertheless, the Chinese government has approved the application of this super vaccine to the general public as an antidote to covid.

Liu Jingzhen, chairman of Sinopharm, said that the super-vaccine does not cause any side effects, but there are some minor problems that can be easily remedied. He further claims that in the current situation, it applies only to those workers, students, who have traveled abroad since the onset of the pandemic. It was found that none of them became infected after the vaccination. As a result, 56,000 passengers traveling from China to other countries were vaccinated on November 8 before departure.

It is learned that the super vaccine made by Sinopharm is currently in the third and final stage of the trial. The test is being performed on more than 60,000 volunteers in 10 countries around the world.

Another US drug manufacturer Pfizer said its vaccine was 95% successful in preventing covid infection, and since then several countries have been calling for effective covid vaccines. Now China has also entered the competition. However, 100% efficacy claims by China seems overboard as none of the other brands have claimed more than 95% efficacy.

Support Indian Spectator by subscribing to our Daily Newsletters. Submit your opinion/articles on Info.indianspectator@gmail.com.

Support Indian Spectator, follow us on Google News. Submit your opinion and guest articles on Info.indianspectator@gmail.com

IS NewsDesk
IS NewsDesk
Stories curated by our interns and news crew. Originally reported or general compilation from various available sources and news agencies.

Latest News

Rooting for Change: Farmer Protests Reignite in India – Exploring Demands, Updates, and Impact

In a momentous resurgence of the farmers' movement, tens of thousands of Indian farmers have once again taken to...

Paytm Navigates Regulatory Challenges: Transitioning Towards a Third-Party App Model

Since its establishment in May 2017, Paytm Payments Bank has encountered a series of regulatory hurdles, culminating in recent...

RBI Halts Paytm Payments Bank: Unraveling the Regulatory Actions

On the 31st of January, a pivotal moment unfolded as the Reserve Bank of India (RBI) issued an unequivocal...

Bharat Ratna for LK Advani: A Tribute to a Stalwart Statesman’s Enduring Legacy in Indian Politics

Renowned BJP stalwart Lal Krishna Advani is set to receive the highest civilian honor in the country, the 'Bharat...

Why Lakshadweep Trails Behind the Maldives: A Look at Geography and Tourism

The proximity of Lakshadweep and the Maldives, two archipelagic islands nestled in the Indian Ocean, raises intriguing questions about...

Is News Media’s Role in Shaping Justice and Priorities a Double-Edged Sword?

In our information-driven world, news platforms play a crucial role in keeping the public informed about significant events and...

Jio AirFiber vs. Airtel Xstream AirFiber: Which One’s Better for You?

Let's dive right into the world of home internet and make choosing between Airtel Xstream AirFiber and Jio AirFiber....

The Dynamics of Free Markets and Buyouts

In the realm of economics, the interplay between free markets and buyouts is a phenomenon experienced by capitalist nations...